We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Bayer Increases Ownership in PharmaNetics

By HospiMedica staff writers
Posted on 02 May 2001
Under a new agreement, Bayer Diagnostics (Tarrytown, NY, USA) has increased its equity ownership from 7% to 19.9% in PharmaNetics (Raleigh, NC, USA), paying US$17.4 million for newly issued shares of stock in the company.

In addition to this investment, the agreement expands the distribution agreement with PharmaNetics to include its Theranostic tests as part of Bayer Diagnostics' critical care product offering. More...
Bayer retains exclusive rights from PharmaNetics to sell and market Theranostic products outside the United States. The two companies will coordinate commercial activities to leverage each other's resources and expertise to best serve market needs. Also, they will collaborate with PharmaNetics' pharmaceutical partners to establish the value of Theranostic testing on a global basis.

Theranostics is a technology platform that allows doctors to determine patient therapy involving certain drugs that affect coagulation by providing rapid testing results on the biologic effects of the drugs. Depending on the application, the tests can act to screen for certain patient subsets, manage dosing, monitor therapy, or determine efficacy.

"We consider PharmaNetics a center of excellence for coagulation testing,” said Fran Tuttle, senior vice president of Bayer Diagnostics' Near Patient Testing segment. "We are excited to have the opportunity to participate in developing the Theranostic market with PharmaNetics.”





Related Links:
Bayer Diagnostics
PharmaNetics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.